Nifty
Sensex
:
:
23501.10
77209.90
-65.90 (-0.28%)
-269.03 (-0.35%)

Pharmaceuticals & Drugs - API

Rating :
49/99

BSE: 532488 | NSE: DIVISLAB

4522.15
21-Jun-2024
  • Open
  • High
  • Low
  • Previous Close
  •  4500.00
  •  4575.95
  •  4489.75
  •  4504.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  583517
  •  26455.22
  •  4627.95
  •  3295.30

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 119,979.85
  • 74.99
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 115,999.85
  • 0.66%
  • 8.84

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.92%
  • 1.36%
  • 8.68%
  • FII
  • DII
  • Others
  • 14.68%
  • 21.62%
  • 1.74%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.86
  • 9.45
  • 3.68

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.84
  • 4.81
  • -3.70

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.96
  • 6.15
  • -2.78

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 39.69
  • 50.42
  • 53.66

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.80
  • 9.01
  • 8.98

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 28.13
  • 32.54
  • 33.71

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
2,303.00
1,951.00
18.04%
1,855.00
1,708.00
8.61%
1,909.00
1,855.00
2.91%
1,778.00
2,255.00
-21.15%
Expenses
1,572.00
1,464.00
7.38%
1,366.00
1,299.00
5.16%
1,430.00
1,234.00
15.88%
1,274.00
1,407.00
-9.45%
EBITDA
731.00
487.00
50.10%
489.00
409.00
19.56%
479.00
621.00
-22.87%
504.00
848.00
-40.57%
EBIDTM
31.74%
24.96%
26.36%
23.95%
25.09%
33.48%
28.35%
37.61%
Other Income
79.00
66.00
19.70%
95.00
113.00
-15.93%
86.00
80.00
7.50%
81.00
88.00
-7.95%
Interest
2.00
0.00
0
0.00
0.00
0
1.00
0.00
0
0.00
0.00
0
Depreciation
95.00
87.00
9.20%
95.00
87.00
9.20%
95.00
86.00
10.47%
93.00
84.00
10.71%
PBT
713.00
466.00
53.00%
489.00
435.00
12.41%
469.00
615.00
-23.74%
492.00
852.00
-42.25%
Tax
175.00
145.00
20.69%
131.00
129.00
1.55%
121.00
122.00
-0.82%
136.00
150.00
-9.33%
PAT
538.00
321.00
67.60%
358.00
306.00
16.99%
348.00
493.00
-29.41%
356.00
702.00
-49.29%
PATM
23.36%
16.45%
19.30%
17.92%
18.23%
26.58%
20.02%
31.13%
EPS
20.30
12.11
67.63%
13.51
11.55
16.97%
13.13
18.60
-29.41%
13.43
26.45
-49.22%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
7,845.00
7,767.51
8,959.83
6,969.40
5,394.42
4,946.26
3,891.49
4,064.34
3,776.36
3,114.94
2,532.14
Net Sales Growth
0.98%
-13.31%
28.56%
29.20%
9.06%
27.10%
-4.25%
7.63%
21.23%
23.02%
 
Cost Of Goods Sold
3,129.00
3,053.72
2,967.14
2,324.08
2,108.54
1,825.22
1,534.06
1,534.00
1,505.32
1,213.24
914.15
Gross Profit
4,716.00
4,713.79
5,992.69
4,645.32
3,285.88
3,121.04
2,357.43
2,530.34
2,271.04
1,901.70
1,617.99
GP Margin
60.11%
60.69%
66.88%
66.65%
60.91%
63.10%
60.58%
62.26%
60.14%
61.05%
63.90%
Total Expenditure
5,642.00
5,398.40
5,078.72
4,108.34
3,571.21
3,073.24
2,628.74
2,617.20
2,358.04
1,948.69
1,516.76
Power & Fuel Cost
-
496.61
392.33
319.15
280.73
248.78
228.73
198.80
180.34
170.82
147.40
% Of Sales
-
6.39%
4.38%
4.58%
5.20%
5.03%
5.88%
4.89%
4.78%
5.48%
5.82%
Employee Cost
-
975.02
946.16
825.76
621.05
542.27
456.06
499.90
361.19
290.42
232.46
% Of Sales
-
12.55%
10.56%
11.85%
11.51%
10.96%
11.72%
12.30%
9.56%
9.32%
9.18%
Manufacturing Exp.
-
400.93
365.92
297.84
258.91
212.96
182.67
169.15
169.42
147.24
121.10
% Of Sales
-
5.16%
4.08%
4.27%
4.80%
4.31%
4.69%
4.16%
4.49%
4.73%
4.78%
General & Admin Exp.
-
302.99
236.44
175.26
148.62
105.30
139.33
88.22
73.91
63.85
51.74
% Of Sales
-
3.90%
2.64%
2.51%
2.76%
2.13%
3.58%
2.17%
1.96%
2.05%
2.04%
Selling & Distn. Exp.
-
113.82
127.01
124.03
85.36
73.08
64.02
67.48
56.04
51.93
44.22
% Of Sales
-
1.47%
1.42%
1.78%
1.58%
1.48%
1.65%
1.66%
1.48%
1.67%
1.75%
Miscellaneous Exp.
-
55.31
43.72
42.22
68.00
65.63
23.87
59.65
11.80
11.18
44.22
% Of Sales
-
0.71%
0.49%
0.61%
1.26%
1.33%
0.61%
1.47%
0.31%
0.36%
0.22%
EBITDA
2,203.00
2,369.11
3,881.11
2,861.06
1,823.21
1,873.02
1,262.75
1,447.14
1,418.32
1,166.25
1,015.38
EBITDA Margin
28.08%
30.50%
43.32%
41.05%
33.80%
37.87%
32.45%
35.61%
37.56%
37.44%
40.10%
Other Income
341.00
344.66
115.90
62.67
189.63
155.63
113.44
74.89
97.44
44.70
70.60
Interest
3.00
1.96
2.00
2.10
7.14
4.68
2.37
3.36
4.74
2.88
2.96
Depreciation
378.00
343.18
311.51
255.59
186.24
168.90
142.49
123.33
118.18
136.00
92.12
PBT
2,163.00
2,368.63
3,683.50
2,666.04
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
990.92
Tax
563.00
545.25
723.05
681.75
442.92
502.33
354.32
334.92
267.06
220.56
217.58
Tax Rate
26.03%
23.02%
19.63%
25.57%
24.34%
27.08%
28.78%
24.00%
19.17%
20.57%
21.96%
PAT
1,600.00
1,823.38
2,960.45
1,984.29
1,376.54
1,352.74
877.01
1,060.42
1,125.78
851.52
773.34
PAT before Minority Interest
1,600.00
1,823.38
2,960.45
1,984.29
1,376.54
1,352.74
877.01
1,060.42
1,125.78
851.52
773.34
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
20.40%
23.47%
33.04%
28.47%
25.52%
27.35%
22.54%
26.09%
29.81%
27.34%
30.54%
PAT Growth
-12.18%
-38.41%
49.19%
44.15%
1.76%
54.24%
-17.30%
-5.81%
32.21%
10.11%
 
EPS
60.26
68.68
111.50
74.74
51.85
50.95
33.03
39.94
42.40
32.07
29.13

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
12,767.09
11,728.18
9,294.61
7,309.92
6,957.15
5,924.80
5,357.39
4,293.31
3,495.36
2,963.35
Share Capital
53.09
53.09
53.09
53.09
53.09
53.09
53.09
53.09
26.55
26.55
Total Reserves
12,714.00
11,675.09
9,241.52
7,256.83
6,904.06
5,871.71
5,304.30
4,240.21
3,468.81
2,936.80
Non-Current Liabilities
556.36
436.51
363.94
294.57
991.38
1,768.91
1,411.75
85.17
841.57
650.05
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.47
1.05
1.55
Long Term Provisions
30.62
26.71
25.42
20.52
772.54
1,577.26
1,288.92
11.57
714.30
533.49
Current Liabilities
1,533.08
2,454.44
1,728.35
1,820.53
846.75
653.42
659.45
519.50
775.53
627.41
Trade Payables
762.51
795.70
763.20
590.72
492.26
411.21
445.80
232.69
226.87
151.70
Other Current Liabilities
331.44
394.02
340.42
290.09
243.59
175.46
176.63
240.58
203.45
147.80
Short Term Borrowings
0.00
0.00
0.35
33.63
105.60
63.11
35.74
41.42
25.07
16.32
Short Term Provisions
439.13
1,264.72
624.38
906.09
5.30
3.64
1.28
4.81
320.14
311.58
Total Liabilities
14,856.53
14,619.13
11,386.90
9,425.02
8,795.28
8,347.13
7,428.59
4,897.98
5,112.46
4,240.81
Net Block
4,722.60
4,325.05
3,703.87
2,781.85
2,087.77
1,996.19
1,559.19
1,438.77
1,308.89
1,221.84
Gross Block
6,364.76
5,624.27
4,691.86
3,514.25
2,633.93
2,373.45
1,793.95
2,196.08
1,953.02
1,740.34
Accumulated Depreciation
1,642.16
1,299.22
987.99
732.40
546.16
377.26
234.76
757.32
644.13
518.50
Non Current Assets
5,112.79
5,008.74
4,596.30
3,851.49
4,145.23
3,812.01
3,418.08
1,870.93
2,340.06
1,984.45
Capital Work in Progress
211.88
469.93
710.62
919.69
491.91
119.76
443.57
263.91
218.18
144.48
Non Current Investment
77.05
72.01
0.01
0.01
547.26
0.01
0.01
0.01
0.00
0.00
Long Term Loans & Adv.
97.61
133.70
172.59
144.50
1,012.93
1,688.23
1,406.48
162.44
812.63
618.03
Other Non Current Assets
3.65
8.05
9.21
5.44
5.36
7.82
8.83
5.80
0.35
0.09
Current Assets
9,743.74
9,610.39
6,790.60
5,573.53
4,650.05
4,535.12
4,010.51
3,027.04
2,772.40
2,256.35
Current Investments
0.00
0.00
0.00
971.35
1,398.34
1,889.28
1,630.72
802.85
733.00
501.88
Inventories
3,000.41
2,828.62
2,145.23
1,863.86
1,772.34
1,350.67
1,319.91
1,207.83
1,162.64
932.42
Sundry Debtors
1,792.53
2,423.88
1,676.52
1,413.35
1,163.37
1,014.36
900.92
880.92
741.64
723.70
Cash & Bank
4,213.09
2,818.88
2,156.03
122.63
115.26
112.46
78.70
73.43
65.22
40.51
Other Current Assets
737.71
29.69
51.95
52.16
200.74
168.35
80.26
62.01
69.89
57.85
Short Term Loans & Adv.
708.74
1,509.32
760.87
1,150.18
58.54
43.37
59.59
42.88
54.98
48.16
Net Current Assets
8,210.66
7,155.95
5,062.25
3,753.00
3,803.30
3,881.70
3,351.06
2,507.54
1,996.87
1,628.95
Total Assets
14,856.53
14,619.13
11,386.90
9,425.02
8,795.28
8,347.13
7,428.59
4,897.97
5,112.46
4,240.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
2,459.73
1,911.80
1,946.93
1,215.94
954.30
775.86
1,150.37
1,037.86
826.33
556.75
PBT
2,368.63
3,683.50
2,666.04
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
990.92
Adjustment
144.94
239.73
189.29
60.01
83.51
32.19
93.87
60.94
91.24
77.55
Changes in Working Capital
418.81
-1,370.45
-264.08
-218.30
-499.84
-219.11
-37.14
-155.03
-125.55
-298.39
Cash after chg. in Working capital
2,932.38
2,552.78
2,591.25
1,661.17
1,438.74
1,044.41
1,452.07
1,298.75
1,037.76
770.07
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-472.65
-640.98
-644.32
-445.23
-484.44
-268.55
-301.70
-260.89
-211.43
-213.32
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-2,707.62
-2,194.92
75.13
-83.47
-685.40
-478.30
-1,139.60
-406.41
-520.84
-305.15
Net Fixed Assets
-481.51
-691.54
-968.33
-1,302.55
-632.52
-255.54
222.19
-288.75
-286.31
-242.98
Net Investments
-5.04
-72.00
971.35
974.24
-56.30
-257.57
-826.05
-77.22
-231.12
-94.07
Others
-2,221.07
-1,431.38
72.11
244.84
3.42
34.81
-535.74
-40.44
-3.41
31.90
Cash from Financing Activity
-797.17
-532.44
-34.89
-1,091.42
-245.94
-314.16
2.38
-631.12
-302.95
-248.50
Net Cash Inflow / Outflow
-1,045.06
-815.56
1,987.17
41.05
22.96
-16.60
13.15
0.33
2.54
3.10
Opening Cash & Equivalents
1,214.76
2,030.32
43.15
2.10
-20.86
-4.26
-17.41
17.62
15.09
11.99
Closing Cash & Equivalent
169.70
1,214.76
2,030.32
43.15
2.10
-20.86
-4.26
17.95
17.62
15.09

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
480.96
441.82
350.15
275.38
262.09
223.20
201.82
161.73
131.67
111.63
ROA
12.37%
22.77%
19.07%
15.11%
15.78%
11.12%
17.21%
22.49%
18.21%
19.92%
ROE
14.89%
28.16%
23.90%
19.30%
21.00%
15.55%
21.98%
28.91%
26.37%
28.31%
ROCE
19.36%
35.06%
32.07%
25.36%
28.50%
21.68%
28.75%
35.57%
33.06%
36.04%
Fixed Asset Turnover
1.30
1.74
1.70
1.77
1.98
1.88
2.06
1.83
1.70
1.66
Receivable days
98.41
83.26
80.66
86.18
80.35
89.33
79.19
77.83
85.12
88.42
Inventory Days
136.05
100.99
104.66
121.62
115.23
124.56
112.34
113.70
121.69
126.52
Payable days
93.12
95.88
106.32
93.73
52.21
60.15
47.14
35.06
33.55
36.16
Cash Conversion Cycle
141.33
88.36
79.00
114.07
143.37
153.75
144.39
156.47
173.26
178.78
Total Debt/Equity
0.00
0.00
0.00
0.00
0.02
0.01
0.01
0.01
0.01
0.01
Interest Cover
1209.48
1842.75
1270.54
255.83
397.38
520.55
416.28
294.75
373.59
336.24

News Update:


  • Divi's Laboratories reports 68% rise in Q4 consolidated net profit
    27th May 2024, 11:00 AM

    Total consolidated income of the company increased by 18.10% at Rs 2,382 crore for Q4FY24

    Read More
  • Divi's Lab - Quarterly Results
    25th May 2024, 12:51 PM

    Read More
  • Divi's Laboratories planning for capacity addition at manufacturing facility
    25th Apr 2024, 11:53 AM

    The proposed facility is expected to be operational around January 2027

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.